Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diacerein for Insulin Secretion in T2DM
NCT01298882Phase 2Completed
- Sponsor
- Coordinación de Investigación en Salud
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Diacerein with Placebo (2 arms). Primary endpoints: Fasting insulin concentration at 2 months, Fasting glucose concentration at 2 months and 4 more. Status: completed.
02
Drugs
diacerein
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01298882.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01298882.